How early is early for JIA? Insights from the infantile-onset juvenile idiopathic arthritis patients of the PERA research group cohort
Authors:
- Kubra OzturkKOKubra Ozturk
- Tuncay AydinTATuncay Aydin
- Gulcan Ozomay BaykalGBGulcan Ozomay Baykal
- Esra BaglanEBEsra Baglan
- Hulya KoseHKHulya Kose
- Hakan KisaogluHKHakan Kisaoglu
- Deniz Gezgin YildirimDYDeniz Gezgin Yildirim
- Fatma Gul DemirkanFDFatma Gul Demirkan
- Gulcin Otar YenerGYGulcin Otar Yener
- Mustafa ÇakanMÇMustafa Çakan
- Belde Kasap DemirBDBelde Kasap Demir
- Hatice Adiguzel DundarHDHatice Adiguzel Dundar
- 14 August 2025
- journal article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 64 (12) , 6278-6284
Abstract
Objective: Juvenile idiopathic arthritis (JIA) is the most common chronic childhood arthritis, with distinct categories based on pathophysiology and clinical manifestations. The age of onset varies by category but is reported to be approximately six years. This study aimed to evaluate the clinical, laboratory and outcome characteristics of patients with infantile-onset JIA. Methods: This multicentre retrospective study included patients with JIA whose symptoms were onset before the age of two. Results: This study included 199 patients with a median age at symptom onset of 17 months and a median age at diagnosis of 20 months. The most common JIA categories were persistent oligoarticular (59.8%), systemic (13.6%) and rheumatoid factor (RF)-negative polyarticular (11.6%). Patients with symptom onset ≤12 months had a significantly higher prevalence of RF-negative polyarticular and systemic JIA, whereas those with onset >12 months had a higher prevalence of persistent oligoarticular JIA. Antinuclear antibody positivity was significantly higher in patients with disease onset >12 months, whereas uveitis development was more common in those with onset ≤12 months. The wrist, hand proximal interphalangeal (PIP) and foot PIP joints were significantly more frequently affected in patients with early-onset disease. At the last visit, 59.8% of the patients were in remission with medication and 18.1% were in remission without medication. Conclusion: This study suggests that patients with infantile-onset JIA exhibit distinct characteristics regarding JIA category, joint involvement and uveitis development, highlighting the need for further research and potential reconsideration of current age thresholds in the JIA classification.Keywords
This publication has 23 references indexed in Scilit:
- Management of JIA associated uveitisBest Practice & Research Clinical Rheumatology, 2024
- Cumulative Damage in Juvenile Idiopathic Arthritis: A Multicenter Study From the Pediatric Rheumatology Arab GroupArthritis Care & Research, 2020
- Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort studyThe Lancet Child & Adolescent Health, 2019
- Clinical Outcome and Long-term Remission in JIACurrent Rheumatology Reports, 2017
- American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritisArthritis Care & Research, 2011
- Biologic similarities based on age at onset in oligoarticular and polyarticular subtypes of juvenile idiopathic arthritisArthritis & Rheumatism, 2010
- Risk factors for development of uveitis differ between girls and boys with juvenile idiopathic arthritisArthritis & Rheumatism, 2010
- Development and validation of a composite disease activity score for juvenile idiopathic arthritisArthritis Care & Research, 2009
- Systemic onset juvenile idiopathic arthritis-its unusual presentationIndian Journal of Pediatrics, 2008
- Antinuclear Antibody (ANA) and ANA Profile Tests in Children with Autoimmune Disorders: A Retrospective StudyClinical Rheumatology, 2000